Actionable news
All posts from Actionable news
Actionable news in KERX: Keryx Biopharmaceuticals, Inc.,

Glancy Prongay & Murray Commences Investigation on Behalf of Keryx Pharmaceuticals, Inc.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of investors of Keryx Pharmaceuticals, Inc. ("Keryx" or the "Company") (NASDAQ: KERX) concerning the Company and its officers’ possible violations of federal securities laws. GPM is preparing a lawsuit on behalf of injured investors.

Keryx is a biopharmaceutical company that focuses on providing therapies for patients with renal disease in the United States.

On August, 1, 2016 Keryx announced an imminent...